Evaluation of Doxil [doxorubicin] in the treatment of recurrent or advanced leiomyosarcoma of the uterus
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2013
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Uterine cancer
- Focus Therapeutic Use
- 27 Jun 2008 Patient inclusion/exclusion criteria added as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.